| 中文名称: | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin |
| 中文别名: | (S)-6,6'-双(9-菲基)螺环二酚磷酸酯;(11AS)-10,11,12,13-四氢-5-羟基-3,7-二-9-菲基-5-氧化物二茚并[7,1-DE:1',7'-FG][1,3,2]二氧杂膦;(11AS)-10,11,12,13-四氢-5-羟基-3,7-二-9-菲基-二茚并[7,1-DE:1',7'-FG][1,3,2]二氧磷杂八环-5-氧化物 |
| smiles: | O1C2CCC=C3C=2C2(C=C3C3C=C4C(=C5C3=CC=CC5=O)C=CC=C4)C(O)=CC3=C2C(=CC=C3C2C=C3C(=C4C2=CC=CC4=O)C=CC=C3)OP1 |
| 英文名称: | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin |
| 英文别名: | (11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin;(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9- phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2] dioxaphosphocin;(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin,99%e.e.;(11AS)-10,11,12,13-TETRAHYDRO-5-HYDROXY-3,7-DI-9-PHENANTHRENYL-5-OXIDE-DIINDENO[7,1-DE:1',7'-FG][1,3,2]DIOXAPHOSPHOCIN,MIN.98%;(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, min. 98%;Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 10,11,12,13-tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-, 5-oxide, (11aS)- |
| CAS号: | 1585988-92-6 |
| 分子式: | C45H29O5P |
| 分子量: | 680.68 |
| 密度: | |
| 熔点: | |
| 沸点: | |
| 闪点: | |
| 水溶性: | |
| 蒸气压: |
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
英文名:
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
别名:(S)-6,6'-双(9-菲基)螺环二酚磷酸酯;(11AS)-10,11,12,13-四氢-5-羟基-3,7-二-9-菲基-5-氧化物二茚并[7,1-DE:1',7'-FG][1,3,2]二氧杂膦;(11AS)-10,11,12,13-四氢-5-羟基-3,7-二-9-菲基-二茚并[7,1-DE:1',7'-FG][1,3,2]二氧磷杂八环-5-氧化物
商品编号:R038529-50mg
规格:50mg
纯度:≥98%,99%e.e.
CAS号: 1585988-92-6
分子式:C45H29O5P
分子量:680.68
| 价格 |
¥ 866.00
(请 登录 会员查看折扣价)
|
| 货期 | 5~7个工作日 |
数量
搜索质检报告(COA)
搜索MSDS
相关产品


















